Related Experiment Video
Updated: Jul 13, 2026
14:21
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Emerging pharmacotherapies for smoking cessation
Candice L Garwood1, Lisa A Potts
1Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA. cgarwood@wayne.edu
Summary
Emerging therapies for tobacco dependence target key neurotransmitter systems, offering new hope for smoking cessation. These treatments aim to improve success rates and reduce relapse by addressing nicotine addiction mechanisms.
Area of Science:
- Neuroscience of addiction
- Pharmacology of smoking cessation
Background:
- Nicotine dependence involves complex neurobiological pathways, primarily mediated by dopamine.
- Existing pharmacotherapies like bupropion and varenicline target neurotransmitter systems implicated in addiction.
Purpose of the Study:
- To review the neurobiology of tobacco dependence.
- To evaluate the efficacy and safety of emerging pharmacotherapies for smoking cessation.
Main Methods:
- Review of scientific literature on nicotine addiction and smoking cessation treatments.
- Analysis of current and developing pharmacologic interventions targeting neurotransmitter systems.
Main Results:
- Dopamine is central to nicotine's addictive properties, influenced by GABA, acetylcholine, glutamate, norepinephrine, serotonin, opioids, and endocannabinoids.
- Emerging therapies include rimonabant (cannabinoid antagonist) showing potential for cessation and weight management, and three nicotine vaccines in development.
- New nicotine-replacement formulations are also under investigation.
Conclusions:
- Promising new products are being developed to target tobacco dependence mechanisms.
- These emerging therapies may provide more options for smoking cessation and address high relapse rates.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...